Zyprexa and Sedation - a phase IV clinical study of FDA data
Summary:
Sedation is found among people who take Zyprexa, especially for people who are female, 20-29 old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Zyprexa and have Sedation. It is created by eHealthMe based on reports of 62,725 people who have side effects when taking Zyprexa from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
62,725 people reported to have side effects when taking Zyprexa.
Among them, 1,964 people (3.13%) have Sedation.
What is Zyprexa?
Zyprexa has active ingredients of olanzapine. It is often used in bipolar disorder. eHealthMe is studying from 64,019 Zyprexa users for its effectiveness, alternative drugs and more.
What is Sedation?
Sedation is found to be associated with 2,393 drugs and 1,257 conditions by eHealthMe.
Number of Zyprexa and Sedation reports submitted per year:

Time on Zyprexa when people have Sedation *:
Gender of people who have Sedation when taking Zyprexa*:
Age of people who have Sedation when taking Zyprexa *:
Common drugs people take besides Zyprexa *:
Common side effects people have besides Sedation *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Zyprexa and have Sedation?
Check whether Sedation is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Gupta SK, Shwetank B, "Reversible bilateral sensori-neural hearing loss due to olanzapine in a male suffering from bipolar affective disorder", Indian journal of pharmacology, 2014 Jan .
- Og?odek E, Szota A, Araszkiewicz A, "Olanzapine-induced neuroleptic malignant syndrome after 10 years of treatment", Aust NZJ Psychiatry, 2013 Oct .
Related studies
How severe was Sedation and when was it recovered:
Expand to all the drugs that have ingredients of olanzapine:
- Sedation and drugs with ingredients of olanzapine (3,044 reports)
Alternative drugs to, pros and cons of Zyprexa:
- Zyprexa (64,019 reports)
Common Zyprexa side effects:
- Diabetes: 6,914 reports
- Weight increased: 5,992 reports
- Type 2 diabetes: 3,040 reports
- High blood pressure: 2,928 reports
- High blood cholesterol: 2,884 reports
Browse all side effects of Zyprexa:
a b c d e f g h i j k l m n o p q r s t u v w x y zSedation treatments and more:
- Sedation (50,120 reports)
COVID vaccines that are related to Sedation:
- Sedation in Moderna COVID Vaccine
- Sedation in Pfizer BioNTech Covid Vaccine
- Sedation in Johnson and Johnson Covid Vaccine
Common drugs associated with Sedation:
- Zyprexa: 1,964 reports
- Risperdal: 1,920 reports
- Morphine: 1,869 reports
- Olanzapine: 1,722 reports
- Clozapine: 1,598 reports
- Risperidone: 1,576 reports
- Abilify: 1,345 reports
- Aripiprazole: 1,344 reports
- Gabapentin: 1,309 reports
- Omeprazole: 1,233 reports
All the drugs that are associated with Sedation:
- Sedation (2,393 drugs)
Common conditions associated with Sedation:
- Schizophrenia: 2,608 reports
- Pain: 2,231 reports
- Depression: 1,982 reports
- High blood pressure: 1,229 reports
- Bipolar disorder: 961 reports
- Stress and anxiety: 942 reports
All the conditions that are associated with Sedation:
- Sedation (1,257 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on olanzapine (the active ingredients of Zyprexa) and Zyprexa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- How effective is Prednisone for Mixed Connective Tissue Disease? - 7 seconds ago
- Naproxen and Blood Immunoglobulin A Increased - 8 seconds ago
- Tramadol and Ectopic Pregnancy - 13 seconds ago
- Hydrochlorothiazide and Atrioventricular Block First Degree - 18 seconds ago
- Tegison and Muscle Cramps - 19 seconds ago
- Betamethasone Dipropionate and Injection Site Pain - 24 seconds ago
- Mometasone Furoate and Pain Of Skin - 24 seconds ago
- Hydrocortisone and Clomid drug interaction - 29 seconds ago
- Kidney Stones in Concerta, how severe and when it was recovered? - 29 seconds ago
- Klonopin and Latuda drug interaction - 32 seconds ago